Pharmalot... Pharmalittle... Good Morning

Rise and shine, everyone. Another snowy day is on the way. Already, in fact, the chilly Pharmalot corporate campus makes for a splendid winter scene. Pleasant distractions aside, there is much to be done. So please join us as we brew another cup of piping hot stimulation and ready ourselves for another stab at the to-do list. Meanwhile, here are a few items of interest. Hope your day goes well and you stay warm... Branded Pharma Revenues To Rise 3 Percent In 2014: Fitch (Pharma Times) Roche Shares Drop On Speculation Novartis Will Sell Its Stake (Bloomberg News) New Medicines Arrive, But There Are Fewer Blockbusters (The Wall Street Journal) Top 10 Social Media Firsts In Pharma In 2013 (Pharmaphorum) Teva Abandons Plan To Build Factory In India (Pharma & Medical Packaging News) Endo Health Buys NuPathe For $105 Million (The Philadelphia Inquirer) Torrent Pharma Buys Elder For $323 Million (The Economic Times) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs